The PSI 2022 Conference will run between Sunday 12th to Wednesday 15th June 2022.
Regarded as the principal annual event for statisticians in the pharmaceutical industry and following on from our highly successful 2021 online conference, the 2022 PSI Conference will be taking place at Gothia Towers in Gothenburg, Sweden.
Registration will open in November, with the early bird deadline for registrations on 25 March 2022.
The conference will consist of a variety of plenary and parallel sessions, as well breakout discussion sessions, workshops, a poster session and the annual general meeting. Please note the conference will be a full 3 days from Monday to Wednesday, with an optional half day training course on Sunday afternoon (at an additional cost). A draft agenda will be released later.
Submission for oral and poster abstracts is now open.
Please note the submission deadlines:
We will be welcoming abstracts on any subject but will be particularly interested in the following:
If you are a career young statistician (approximately less than 5 years working in the pharmaceutical industry) then you will have the option to present in a dedicated contributed session alongside your peers. This is a great opportunity to gain experience in presenting in a friendly environment and to network with those of a similar experience at other companies.
Given the success of our 1 minute poster preview in the last few years, anyone selected for a poster, will be asked if they would like to give a 1 minute presentation on their poster, to give people a brief insight into their work, as part of the final session on the Monday, leading into the poster session.
We hope you will join us in building on the huge success of previous conferences and make 2022 in Gothenburg an even greater event.
David Lawrence
PSI Conference Chair
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI are starting a book club! We will be reading/discussing non-technical books relevant to our roles. Participants will be split into smaller groups to network with each other and practice exercises.
Learn from others in the PSI Community who also associate with Imposter Syndrome. They will discuss the topic, give their own personal views and experiences and provide tips to beat it.
Complex Innovative Designs: overview and case studies from FDA pilot program and considerations on master protocols.
Here, we show how to estimate potentially time-varying placebo-controlled vaccine efficacy in this type of staggered vaccination of participants.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
In just 1 hour, learn about the field of medical statistics and how it plays a crucial role in developing ground-breaking new medicines, vaccines and healthcare products.
Overview and Recent methodological Advances for Identifying Treatment Effect Heterogeneity in Clinical Trials.
Building on the previous webinar series we will present a refresher on the key elements of the estimand framework and use the ETHOS study.
Our annual PSI Medical Statistics Careers Event, will be held online on Wednesday 2nd March 2022. The event will include a live online panel discussion and a virtual exhibition session.
For our global team in Europe we are seeking highly qualified candidates to fill the position of Global Director Biostatistics (m/f/x).
Joining us as Principal Biostatistician you will be responsible for providing statistical support of global clinical development programs in neuroscience.
The Senior Manager Biostatistics will be responsible for leading biostatistics strategy and activities for a compound and/or for individual clinical studies.
Novartis is establishing a virtual Analytics Network in the UK and we are currently recruiting PhD graduates to join this exciting new group!
